Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-99,500
Closed -$7.76M 4309
2024
Q1
$7.76M Buy
+99,500
New +$7.4M 0.01% 1154
2023
Q2
Sell
-22,700
Closed -$1.83M 3742
2023
Q1
$1.83M Sell
22,700
-1,700
-7% -$137K 0.01% 1479
2022
Q4
$1.83M Buy
+24,400
New +$1.74M 0.01% 1426

Other funds holding HOLX

Squarepoint's HOLX Position: Q1 2026 in Review

Squarepoint increased its Hologic (HOLX) stake by 11% in Q1 2026, buying an estimated $8.87M and bringing the position to 1,152,092 shares worth $87.1M. The position accounts for 0.1% of the portfolio, ranked #193.

Squarepoint first reported a position in HOLX in Q4 2015 and has held it in 32 quarters since. 703 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Squarepoint held 1,152,092 shares of Hologic worth $87.1M as of Q1 2026.
  • Squarepoint bought 118,025 Hologic shares in Q1 2026, an estimated $8.87M.
  • Hologic made up 0.1% of Squarepoint's portfolio in Q1 2026, its #193 holding.
  • Squarepoint first reported a position in Hologic in Q4 2015 and has held it in 32 quarters since.
  • 703 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.